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Abstract
The primer tRNA for reverse transcription in HIV-1, tRNALys3, is selectively packaged into the virus
during its assembly, and annealed to the viral genomic RNA. The ribonucleoprotein complex that
is involved in the packaging and annealing of tRNALys into HIV-1 consists of Gag, GagPol, tRNALys,
lysyl-tRNA synthetase (LysRS), and viral genomic RNA. Gag targets tRNALys for viral packaging
through Gag's interaction with LysRS, a tRNALys-binding protein, while reverse transcriptase (RT)
sequences within GagPol (the thumb domain) bind to tRNALys. The further annealing of tRNALys3
to viral RNA requires nucleocapsid (NC) sequences in Gag, but not the NC sequences GagPol. In
this report, we further show that while the RT connection domain in GagPol is not required for
tRNALys3 packaging into the virus, it is required for tRNALys3 annealing to the viral RNA genome.
Background
During assembly of HIV-1, the major tRNALys isoacceptors
in mammalian cells, tRNALys1,2 and tRNALys3, are selec-
tively incorporated into the virus [1]. tRNALys3  is the
primer for initiating minus-strand cDNA synthesis, and its
annealing to the 18 nucleotide primer binding site (PBS)
region in the 5' part of the viral genome via the 3' 18
nucleotides in tRNALys3 complementary to the PBS, is a
key step in viral replication [2]. Other regions upstream
and downstream of the PBS may also anneal with addi-
tional sequences in the tRNA [3,4].
Both tRNALys3 and sites of annealing in viral RNA contain
double stranded regions which may require denaturation
for annealing to proceed efficiently. Nucleocapsid protein
(NC) has been shown to facilitate tRNALys3 annealing
both in vitro [5,6] and in vivo [7], primarily through basic
amino acids flanking the first zinc finger. While NC may
destabilize viral RNA secondary structure, it has been
demonstrated by several groups that nucleocapsid protein
does not unwind the secondary structure of tRNA in vitro,
and that the protein only has very subtle tertiary structural
and helix destabilization effects on tRNALys3 alone [8-11].
Although processed nucleocapsid proteins have been
shown to facilitate tRNALys3 annealing to genomic RNA in
vitro, the annealing of primer tRNA onto the genomic
RNA within HIV-1, murine leukemia virus, and avian ret-
rovirus occurs independently of precursor protein
processing [12-14]. However, while, tRNALys3 is annealed
efficiently in protease-negative HIV-1 (about 80% that
found in wild-type virions), optimal placement on the
viral genome to achieve efficient initiation of reverse tran-
scription requires exposure of the viral genome to mature
nucleocapsid protein [15]. In these protease-negative
viruses, mutations in NC sequences within Gag inhibit
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tRNALys3 annealing, while mutations in NC sequences
within GagPol do not, indicating the importance of Gag
NC sequences in the annealing [16]. In vitro, Gag has been
reported to facilitate tRNALys3 annealing to viral RNA as
efficiently as mature NC [17].
Nevertheless, we will present evidence in this report that
GagPol still plays an important role in tRNALys3 annealing
onto the viral RNA, independent of its role in the packag-
ing of tRNALys3 into the virion. We present data herein
indicating that the RT connection domain, while non-
essential for tRNALys3  incorporation into virions, is
required for tRNALys3 annealing to the viral RNA genome
Results
The RT connection domain within GagPol is not required for
tRNALys incorporation into virions, but is required for the
annealing of tRNALys3 to the viral genome.
293T cells were transfected with protease-negative HIV-1
proviral DNA coding for either full length, protease-nega-
tive, GagPol (BH10.P-) or C-terminally deleted GagPol
species. The different constructs are shown in Figure 1A,
and are named according to the number of amino acids
deleted from the C terminus of GagPol. Figure 1B shows
Western blots of lysates of the viruses produced from the
different transfections, probed with anti-CA, and shows
that all forms of GagPol deletion mutants tested here are
incorporated into the virion. Total viral RNA was isolated
from these virions, and dot blots of this RNA were
annealed with probes specific for either viral genomic
RNA or tRNALys3, to determine the tRNALys3/genomic RNA
in each viral variant. These results are shown graphically
in Figure 1C, and support our previous results using COS7
cells [18], which indicate that tRNALys incorporation into
virions is not dramatically affected until GagPol
sequences including the thumb domain of RT are deleted
(∆581 and ∆715).
To measure the amount of tRNALys3 annealed in vivo to the
viral RNA genome, total viral RNA was used as the source
of primer/template in an in vitro reverse transcription reac-
tion, using exogenous HIV-1 RT, dCTP, dTTP, α-32P-dGTP,
and ddATP. This assay measures the amount of extenda-
ble tRNALys3 placed onto the viral genome. It is not known
if all annealed tRNALys3 is extendable. Since the sequence
of the first six dNTP's incorporated is CTGCTA, annealed
primer tRNALys3 will be extended by 6 bases, and the
extended tRNALys3 can be resolved and detected by one
dimensional polyacrylamide gel electrophoresis (1D
PAGE). These results are shown in Figure 2A, and pre-
sented graphically in Figure 2B. The left side of panel A
shows that there is a linear increase in the reverse tran-
scription signal over an almost 10 fold change in the
amount of BH10.P- viral genomic RNA used in the reac-
tion. The data in the right side of panel A indicate that C-
terminal deletions of GagPol extending into the connec-
tion domain result in an 85% or greater decrease in the
initiation of reverse transcription. Thus, the data in Fig-
ures 1 and 2 indicate that deletions extending into the RT
connection domain do not significantly effect tRNALys
incorporation, but do severely reduce the ability of
tRNALys3 to be functionally annealed to the viral RNA
genome.
Rescue of tRNALys3 annealing by GagPol
As shown in Figure 3, this annealing defect can be rescued
by coexpression of full-length GagPol. 293T cells were
transfected with plasmids coding for BH10P-, ∆467, or
∆486, or cotransfected with either ∆467 or ∆486 and a
plasmid coding for full-length GagPol. Western blots of
cell lysates probed with anti-RT or anti-β-actin are shown
in panel A, while Western blots of lysates of virus pro-
duced from these cells and probed with anti-RT and anti-
CA are shown in panel B. These data indicate that both
full length GagPol and the truncated GagPol are incorpo-
rated into the viruses with similar efficiencies. As previ-
ously indicated in Figure 1C, the mutant virions
incorporate approximately 80–85% of the tRNALys3 as
BH10P-, but cotransfection of mutant DNA with DNA
coding for GagPol gives a small increase in tRNALys3 pack-
aged to over 90% of BH10P- (Figure 3C).
As shown in panels D and E, cotransfection with GagPol
also moderately rescues tRNALys3  annealing in these
mutant virions. Using equal amounts of total viral RNA as
the source of primer/template in the in vitro RT assay, the
ability of primer tRNALys3 to be extended 6 deoxynucle-
otides is shown in panel D, which shows the extended 6
base product resolved by 1D PAGE. Quantitation of these
bands by phosphorimaging is presented graphically in
panel E. As previously shown (Figure 2), tRNALys3 anneal-
ing is reduced to 12–15% that of BH10P-, but can be
increased 4–5 fold by the additional presence of full-
length GagPol. The fact that tRNALys3 annealing is only
rescued by GagPol to approximately 50–55% the level of
that obtained when only wild-type GagPol is present may
reflect the fact that in these rescue experiments, the viral
population contains approximately equal amounts of
wild-type and mutant GagPol (Figure 3B).
Attempts were also made to rescue tRNALys3 annealing
using mature RT fused to Vpr [19], but unlike full-length
GagPol, the Vpr-RT was unable to rescue tRNALys3 anneal-
ing in the mutant virions (data not shown).
Discussion
In vitro studies of the interaction between purified RT and
tRNALys3 have indicated an interaction between the RT
thumb domain and the tRNA [20-22]. In vivo studies alsoRetrovirology 2004, 1:33 http://www.retrovirology.com/content/1/1/33
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The incorporation of GagPol and tRNALys3into wild-type and mutant HIV-1 Figure 1
The incorporation of GagPol and tRNALys3into wild-type and mutant HIV-1. A. Schematic showing the deletions made in the Pol 
region of GagPol. ∆# designates the number of amino acid residues deleted from the C terminus of GagPol, and solid black 
lines represent the sequences not deleted. The RT sequence is divided into its known structural domains. The mutation D25G 
inactivates the viral protease. B. Western blots of viral lysates, probed with both anti-CA and anti-RT as previously described 
[18]. C. Incorporation of tRNALys3 into wild-type and mutant virions. Dot blots of viral RNA were hybridized with probes spe-
cific for tRNALys3 or genomic RNA, and the tRNALys3:genomic RNA ratios, normalized to BH10.P- were determined by phos-
phorimaging. The values are the means +/- standard deviations of experiments performed three or more times.
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indicate an important role of the RT thumb domain in
GagPol in tRNALys3 viral packaging. tRNALys3 incorpora-
tion into HIV-1 is not affected by deletion of the IN
domain in GagPol, nor by further deletion of the RNaseH
tRNA Lys3 annealing to viral genomic RNA Figure 2
tRNALys3 annealing to viral genomic RNA. A. Total viral RNA was used as the source of primer tRNALys3/viral RNA template in an 
in vitro reverse transcription reaction as described in Methods. Six base extended tRNALys3 was resolved by 1D PAGE and 
quantitated by phosphorimaging. Each reaction used an equal amount of viral genomic RNA, as determined by hybridization 
with a genomic RNA-specific probe. B. Graphic presentation of 6 base-extended tRNALys3:genomic RNA ratios, normalized to 
BH10P-. The values are the means +/- standard deviations of experiments performed three or more times.
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and connection domains in RT, but is severely inhibited
by further deletion of the thumb domain as well [18].
Thus tRNALys3 interacts with the RT thumb domain during
incorporation into virions, and Gag nucleocapsid plays a
role in promoting tRNALys3 annealing to viral RNA [5-7],
presumably through a denaturation of annealing RNA
sequences.
What then is the role the RT connection domain sequence
in GagPol in facilitating tRNALys3 annealing? One possi-
bility, suggested by in vitro studies, is that RT plays a direct
role in tRNALys3 annealing. Early work indicated that the
in vitro annealing of primer tRNATrp to AMV genomic RNA
was promoted by the addition of AMV reverse tran-
scriptase [23]. In a later work, in which it was
Rescue by GagPol of tRNALys3 annealing in mutant virions Figure 3
Rescue by GagPol of tRNALys3 annealing in mutant virions. COS7 cells were transfected with either BH10P-, ∆467.P-, or ∆486.P-, 
and were also cotransfected with one of these plasmids and a plasmid coding for full-length GagPol (hGagPol∆FS∆PR). A. 
Western blots of cell lysates, probed with anti-RT or anti-β-actin. B. Western blots of viral lysates, probed with anti-RT and 
anti-CA. C. Incorporation of tRNALys3 into wild-type and mutant virions. Dot blots of viral RNA were hybridized with probes 
specific for tRNALys3 or genomic RNA, and the tRNALys3:genomic RNA ratios were determined by phosphorimaging. The val-
ues are the means +/- standard deviations of experiments performed three or more times. D,E. tRNALys3 annealing in wild-
type and mutant virions. tRNALys3 annealing was measured as described in the Figure 2 legend. The values shown in E are the 
means +/- standard deviations of experiments performed three or more times.
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demonstrated that HIV-1 RT interacted with the D arm
and TΨC loop of tRNALys3, HIV-1 RT was also shown facil-
itate the in vitro annealing of tRNALys3 to the PBS sequence
[24]. These in vitro works suggest that RT alone can directly
promote tRNALys3 annealing to viral RNA. Whether the RT
sequences in GagPol can function similarly in vivo is not
known.
Alternatively, the RT connection domain may undergo
interactions with Gag that may result in placing the
tRNALys3 bound to the thumb domain in RT closer to
either NC in Gag or to the genomic RNA that is bound to
Gag NC. Recent work has indicated that that Pol
sequences alone can bind to Gag p6 through the RT
sequences in Pol [25]. Pol protein alone is sufficient for
obtaining both tRNALys incorporation into the virus and
tRNALys3 annealing to the viral genome at levels approxi-
mately 35% those achieved using full-length GagPol.
Thus, in addition to the interactions which probably
occur between Gag and homologous sequences in the Gag
part of GagPol, the interaction of RT sequences in GagPol
with Gag p6 could place the RT-bound tRNALys3 closer to
Gag NC sequences and viral RNA in the packaging com-
plex. It remains to be determined which sequences within
RT bind to Gag p6, but if it were those of the connection
domain, this could explain how these sequences could
promote tRNALys3 annealing through altering the configu-
ration of GagPol.
Thus, two separate RT domains (thumb and connection)
appear to be involved, respectively, in the viral incorpora-
tion of tRNALys3, and its annealing to HIV-1 RNA. One
also finds two separate domains in Gag involved in these
same processes. Evidence has been presented supporting
the role of lysyl-tRNA synthetase (LysRS) in targeting tRN-
ALys for viral incorporation, through a specific interaction
of Gag capsid sequence with LysRS in a tRNALys/LysRS
complex [26], while other evidence shows that Gag nucle-
ocapsid sequence is involved in tRNALys3  annealing
[6,16,17]. It is not known if LysRS plays any direct role in
tRNALys3 annealing, and LysRS may be required to dissoci-
ate from tRNALys3 so as to free this tRNA for annealing to
the viral RNA.
Methods
Plasmid construction
BH10 and BH10P- are protease-positive and protease-neg-
ative strains of HIV-1, respectively [18]. All deletions
mutants used here were derived from BH10.P-, and their
construction has been previously described [18]. hGag-
Pol∆FS∆PR was a gift from Y. Huang and G. Nabel [27]. It
was constructed by deleting 5 thymidines in the frame
shift site, and codes for GagPol. The codons have opti-
mized for mammalian cell codon usage, which results in
more efficient translation and protein production, and
also makes nuclear export of these mRNAs Rev-independ-
ent through modification of the INS [27,28]. hGag-Pol-
∆FS∆PR contain an inactive protease due to an R42G
mutation in the active site.
Production of wild type and mutant HIV-1 virus
Transfection of COS7 cells with wild type and proviral
DNA was performed using the calcium phosphate
method as previously described [29]. Briefly, virus were
isolated from the cell culture medium 63 hours post-
transfection. The supernatant was first centrifuged in a
Beckman GS-6R rotor at 3000 rpm for 30 minutes, and
the virus were then pelleted from the resulting superna-
tant by centrifuging in a Beckman Ti45 rotor at 35,000
rpm for one hour. The viral pellet was then purified by
centrifugation at 26,500 rpm for 1 hour through 15%
sucrose onto a 65% sucrose cushion, using a Beckman
SW41 rotor.
Protein Analysis
Viral particles were washed with 1X TNE and cellular or
viral proteins were extracted with 1X RIPA buffer (10 mM
Tris pH 7.4; 100 mM NaCI; 1% DOC; 0.1% SDS;
1%NP40; 2 mg/ml Aprotinin; 2 mg/ml Leupeptin; 1 mg/
mlPepstatin A; 100 mg/ml PMSF). Western analysis was
performed using 300 mg cellular protein or 10 µg viral
protein, as determined by the Bradford assay [30]. The cel-
lular and viral lysates were resolved by SDS-1D PAGE, fol-
lowed by blotting onto nitrocellulose membranes
(Gelman Sciences). Detection of protein on Western blots
utilized monoclonal antibodies or antisera specifically
reactive with viral capsid (mouse antibody, Intracel), viral
reverse transcriptase (rabbit antibody), or β-actin (mouse
antibody, Sigma Aldrich). Western blots were analyzed by
enhanced chemiluminescence (ECL kit, Amersham Life
Sciences) using goat anti-mouse or donkey anti-rabbit
(Amersham Life Sciences) as a secondary antibody, and
quantitated using UN-SCAN-IT gelTM automated digitiz-
ing system. The sizes of the detected protein bands were
estimated using pre-stained high molecular weight pro-
tein markers (GIBCO/BRL).
RNA Isolation and Analysis
Total viral RNA was extracted from viral pellets by the gua-
nidinium isothiocyanate procedure [31], and dissolved in
5 mM Tris buffer, pH 7.5. To measure the incorporation
of tRNALys3 into virions, hybridization to dot-blots of viral
RNA was carried out with DNA probes complementary to
tRNALys3 [1] or to genomic RNA [16]. To measure the
amount of tRNALys3 annealed to genomic RNA, tRNALys3-
primed initiation of reverse transcription was measured
using total viral RNA as the source of primer tRNA/tem-
plate in an in vitro HIV-1 reverse transcription reaction, as
previously described [32]. The sequence of the first 6
deoxynucleoside triphosphates incorporated is CTGCTA,Retrovirology 2004, 1:33 http://www.retrovirology.com/content/1/1/33
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and in the presence of dCTP, dGTP, dTTP, and ddATP,
tRNALys3 is extended by 6 bases, and this product can be
resolved by 1D PAGE, and quantitated by phosphorimag-
ing, as previously described [15].
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